C12Y 302/01033
Amylo-alpha-1,6-glucosidase
Official title: Amylo-alpha-1,6-glucosidase (3.2.1.33)
C12Y302/01033 (Amylo-alpha-1,6-glucosidase) appears on 15 US grants and 28 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 28
- Assignees
- 27
- Inventors
- 68
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 1 | 3 |
| 2022 | 2 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 3 |
| 2025 | 1 | 0 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutics for glycogen storage disease type iii11 Aug 2026US 12,703,858 B2Ultragenyx Pharmaceutical Inc.
- Mini-GDE for the treatment of glycogen storage disease III26 May 2026US 12,637,668 B2Association Institut De Myologie
- IL-15-based fusions to IL-7 and IL-219 Sep 2025US 12,410,224 B2Altor BioScience Corporation
- IL-15-based fusions to IL-7 and IL-2123 Apr 2024US 11,965,007 B2Altor BioScience Corporation
- Bakers's yeast expressing anti-staling/freshness amylases5 Dec 2023US 11,834,484 B2Novozymes A/S
- Mini-gde for the treatment of glycogen storage disease iii10 Sep 2026US 2026/0265720 A1Association Institut De Myologie
- N-terminal truncated gde for the treatment of glycogen storage disease iii20 Aug 2026US 2026/0242762 A1Genethon
- Method for preparing a substrate for fermentation2 Jul 2026US 2026/0185123 A1
- Hybrid aav vector enhancing transgene expression in the liver21 May 2026US 2026/0139270 A1Genethon
- Senescence treatment with il-15-based fusions to il-7 and il-217 Nov 2024US 2024/0368237 A1Altor BioScience Corporation
Most cited
By later US patents
- Process for producing .alpha.-1,6 glucosidases using thermophilic microorganisms24US 4,011,139 AStandard Brands Incorporated · 1977
- Non-dairy, ready-to-use milk substitute, and products made therewith23US 6,451,369 B1Cereal Base CEBA AB · 2002
- Enzyme preparations for modifying cereal suspensions14US 6,190,708 B1Cereal Base CEBA AB · 2001
- Method for manufacture of maltose from starch by enzymes co-produced by a single microorganism6US 3,992,261 AAgency of Industrial Science and Technology · 1976
- Messenger UNA molecules and uses thereof5US 10,815,463 B2Arcturus Therapeutics, Inc. · 2020